Found 659 matching trials
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors PHASE2 Drugs called checkpoint inhibitors help the immune system fight cancer. Whe...
Show More Status
Active Not Recruiting
Location
Hartford Healthcare
Learn More & Join Trial
Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases PHASE2 This phase II trials studies how well pembrolizumab and vactosertib work af...
Show More Location
University of California, San Francisco
Learn More & Join Trial
A Study of Pembrolizumab in Patients With Relapsed Or Metastatic Osteosarcoma Not Eligible for Curative Surgery PHASE2 This is a phase II, single arm, open-label, interventional trial of pembrol...
Show More Location
Istituto Ortopedico Rizzoli
Learn More & Join Trial
De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction PHASE2 Immunotherapeutic approaches recently have demonstrated clinical efficacy i...
Show More Location
Aix-en-Provence - CH
Learn More & Join Trial
Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer PHASE2 The primary scientific question of interest of this study is whether the co...
Show More Location
Multiple Locations
Learn More & Join Trial
ITIL-168 in Advanced Solid Tumors PHASE1 DELTA-2 is a phase 1 clinical trial to evaluate the safety, feasibility, an...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer PHASE2 This is a single-arm open-label multi-cohort Phase II study evaluating the ...
Show More Status
Active Not Recruiting
Location
NYU Perlmutter Cancer Center
Learn More & Join Trial
Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer PHASE2 This phase II trial tests whether panitumumab and pembrolizumab in combinat...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer PHASE2 This is a study of HB-202/HB-201 alternating 2-vector therapy with pembroli...
Show More Location
Multiple Locations
Learn More & Join Trial
An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942) PHASE2 The purpose of this study is to assess whether postoperative adjuvant thera...
Show More Status
Active Not Recruiting
Location
University of Arizona
Learn More & Join Trial